We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIC
4126
DELISTED
Otonomy, Inc.
OTIC
$12K ﹤0.01%
4,814
+3,593
+294% +$7.64K
GTPB
4127
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$12K ﹤0.01%
1,188
+855
+257% +$8.35K
FSSI
4128
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$12K ﹤0.01%
1,219
+1,153
+1,747% +$11.2K
RADA
4129
DELISTED
Rada Electronic Industries Ltd
RADA
$12K ﹤0.01%
870
-1,949
-69% -$22.2K
BRPMU
4130
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
$12K ﹤0.01%
1,190
+100
+9% +$1.02K
MBII
4131
DELISTED
Marrone Bio Innovations, Inc.
MBII
$12K ﹤0.01%
11,232
-2,582
-19% -$1.95K
WVFC
4132
DELISTED
WVS Financial Corp
WVFC
$12K ﹤0.01%
824
+144
+21% +$2.2K
SWI
4133
DELISTED
SolarWinds Corporation Common Stock
SWI
$12K ﹤0.01%
897
-4,398
-83% -$57.9K
DZSI
4134
DELISTED
DZS Inc. Common Stock
DZSI
$12K ﹤0.01%
835
+100
+14% +$1.45K
ACXP icon
4135
Acurx Pharmaceuticals
ACXP
$6M
$11K ﹤0.01%
+166
New +$13K
ADIL
4136
Adial Pharmaceuticals
ADIL
$10.5M
$11K ﹤0.01%
+8
New +$11K
ALGS icon
4137
Aligos Therapeutics
ALGS
$43M
$11K ﹤0.01%
196
+118
+151% +$9.45K
ALTY icon
4138
Global X Alternative Income ETF
ALTY
$45.8M
$11K ﹤0.01%
+810
New +$10.4K
AMWD
4139
DELISTED
American Woodmark
AMWD
$11K ﹤0.01%
223
+123
+123% +$7.07K
AOMR
4140
Angel Oak Mortgage REIT
AOMR
$207M
$11K ﹤0.01%
692
-36
-5% -$596
AVTX icon
4141
Avalo Therapeutics
AVTX
$1.05B
$11K ﹤0.01%
5
+2
+67% +$5.02K
AXTI icon
4142
AXT Inc
AXTI
$5.35B
$11K ﹤0.01%
1,559
-177
-10% -$1.33K
BAK icon
4143
Braskem
BAK
$777M
$11K ﹤0.01%
+570
New +$10.8K
BATRA icon
4144
Atlanta Braves Holdings Series A
BATRA
$3.68B
$11K ﹤0.01%
385
-570
-60% -$15.4K
BATRK icon
4145
Atlanta Braves Holdings Series B
BATRK
$3.44B
$11K ﹤0.01%
400
-171
-30% -$4.47K
BKKT icon
4146
Bakkt Inc
BKKT
$345M
$11K ﹤0.01%
74
+50
+208% +$7.12K
BNED icon
4147
Barnes & Noble Education
BNED
$421M
$11K ﹤0.01%
31
-11
-26% -$5.88K
CARM
4148
DELISTED
Carisma Therapeutics
CARM
$11K ﹤0.01%
903
+242
+37% +$3.38K
CDL icon
4149
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$410M
$11K ﹤0.01%
169
+145
+604% +$8.92K
CHCT
4150
Community Healthcare Trust
CHCT
$432M
$11K ﹤0.01%
266
-10,325
-97% -$447K
164 165
166
167 168

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.